Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuan‐Tony Li
Institution:
Sanofi (United States)
Observed institution:
Sanofi (United States)
OpenAlex ID:
A5029701901
Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta‐analysis of non‐Asian studies
2025
·
Philip Home
, Felipe Lauand
, et al.
·
Diabetes Obesity and Metabolism
·
1
PDF
Show more works
View as search
Works count:
1
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type